Amgen settles with FTC over US$28 billion deal
Amgen will be prohibited from leveraging its drug portfolio to disadvantage rivals and will be required to seek prior approval before acquiring related products
Amgen will be prohibited from leveraging its drug portfolio to disadvantage rivals and will be required to seek prior approval before acquiring related products
Erythromycin tablets is used to prevent and treat infections in many different parts of the body
Robots make it to the healthcare conference panel, reflecting the future potential of technology
Amneal’s site in Matoda is one of the company’s 12 pharmaceutical manufacturing facilities
The facility has a potential for capacity expansion up to 2 billion tablets/capsules per year
Reblozyl is the first and only therapy to demonstrate superiority compared to an erythropoiesis stimulating agent (ESA) in MDS-related anemia
Pirfenidone Capsules had estimated annual sales of USD 95 million in the US
Topiramate is the generic version of Supernus Pharmaceuticals’ Trokendi XR
The approval bolsters the company's Mycophenolate Mofetil portfolio
Subscribe To Our Newsletter & Stay Updated